Evaluation of the effects of pulse high-volume hemofiltration in patients with severe sepsis: A preliminary study

International Journal of Artificial Organs

Volumn 33, Issue 8, 2010, Pages 505-511

  Zhang, Peng ^a   Peng, Pai ^a   Wang, Han Min ^a   Zhu, Jun ^a   Liu, Hong Bao ^a   Li, Rong ^a   Huang, Chen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cytokines; Pulse high volume hemofiltration; Sepsis

Indexed keywords

HEMODYNAMICS; PATIENT TREATMENT;

BLOOD-FLOW RATES; CONTROL GROUPS; CONVENTIONAL TREATMENTS; CYTOKINES; EFFECT OF PULSE; HEMOFILTERS; HEMOFILTRATION; HIGH VOLUMES; PULSE HIGH-VOLUME HEMOFILTRATION; SEPSIS;

BLOOD;

ANTIINFLAMMATORY AGENT; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD FILTER; BLOOD FLOW VELOCITY; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS HEMOFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLUID THERAPY; GASTRIC SUCTION; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; MALE; NUTRITIONAL SUPPORT; PERITONEUM LAVAGE; PROTEIN BLOOD LEVEL; PULSE HIGH VOLUME HEMOFILTRATION; RANDOMIZED CONTROLLED TRIAL; SEPSIS; THERAPY EFFECT;

EID: 77957852137     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881003300801     Document Type: Article

References (31)

1. Tetta C, Fonsato V, Ronco C, et al. Recent insights into the pathogenesis of severe sepsis. Crit Care Resusc 2005; 7: 32-9.
2. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-7.
3. Pinsky MR, Vincent JL, Deviere J. Serum cytokine levels in septic shock relation to multiple-system organ failure and mortality. Chest 1993; 103: 565-7.
4. Gogos A, Drosou E, Bassaris HP, et al. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000; 181: 176-80. (Pubitemid 30049046)
5. Smith JW, Gamelli RL, Jones SB, et al. Immunologic responses to critical injury and sepsis. J Intensive Care Med 2006; 21: 160-72.
6. Ronco C. The immunomodulatory effect of extracorporeal therapies in sepsis: a reconciliation of three theories. Int J Artif Organs 2007; 30: 855-7.
7. Ronco C, Bonello M, Bordoni V, et al. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif 2004; 22: 164-74. (Pubitemid 38142302)
8. Natanson C, Hoffman WD, Suffredini AF, et al. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994; 120: 771-83. (Pubitemid 24125299)
9. Bellomo R, Tipping P, Boyce N, et al. Continuous veno-venous hemofiltration with dialysis cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522-6. (Pubitemid 23121799)
10. Heering P, Grabensee B, Brause M. Cytokine removal in septic patients with continuous venovenous hemofiltration. Kidney Blood Press Res 2003; 26: 128-34. (Pubitemid 36677071)
11. Ronco C, Bellomo R, Ricci Z. Continuous renal replacement therapy in critically ill patients. Nephrol Dial Transplant 2001; 16 (Suppl 5): S67-72.
12. Ruffell AJ. The utilization of continuous veno-venous hemo-filtration for the removal of septic mediators in patients with systemic inflammatory response syndrome. Intensive Crit Care Nurs 2003; 19: 207-14.
13. Honore PM, Joannes-Boyau O, Boer W, et al. High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects. Blood Purif 2009; 28: 1-11.
14. Sykora R, Chvojka J, Krouzecky A, et al. High versus standard-volume haemofiltration in hyperdynamic porcine peritonitis: effects beyond haemodynamics? Intensive Care Med 2009; 35: 371-80.
15. Venkataraman R, Kellum JA, Palevsky P. Dosing patterns for continuous renal replacement therapy at a large academic medcal center in the United States. J Crit Care 2002; 17: 246-50. (Pubitemid 35447400)
16. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26-30. (Pubitemid 30416991)
17. Goldfarb S, Golper TA. Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 1994; 5: 228-32.
18. Thomas MC, Harris DCH. Problems and advantages of continuous renal replacement therapy. Nephrology 2002; 7: 110-4.
19. Brendolan A, D'OIntini V, Ricci Z, et al. Pulse high volume hemofiltration. Int J Artif Organs 2004; 27: 398-403.
20. Ratanarat R, Brendolan A, Piccinni P, et al. Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 2005; 9: 294-302.
21. Ratanarat R, Brendolan A, Ricci Z, et al. Pulse High-Volume Hemofiltration in Critically Ill Patients: A New Approach for Patients with Septic Shock. Semin Dial 2006; 19: 69-74. (Pubitemid 43479013)
22. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30: 536-55.
23. Bone RC, Sibbald WJ, Sprung CL, et al. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101: 1481-3.
24. Ghani RA, Zainudin S, Ctkong N, et al. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration. Nephrol 2006; 11: 386-93. (Pubitemid 44470085)
25. Kellum JA, Johnson JP, Kramer D, et al. Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 1998; 26: 1995-2000. (Pubitemid 29016680)
26. Hoffman JN, Hartl WH, Deppisch R, et al. Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances. Kidney Int 1995; 48: 1563-70.
27. Sander A, Armbruster W, Sander B, et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF plasma concentrations. Intensive Care Med 1997; 23: 878-84. (Pubitemid 27417692)
28. Klouche K, Cavadore P, Portales P, et al. Continuous venovenous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNF-a and IL-6 plasma concentrations. J Nephrol 2002; 15: 150-7. (Pubitemid 34594165)
29. Rogiers P, Zhang H, Smail N, et al. Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 1999; 27: 1848-55. (Pubitemid 29455115)
30. Pascual M, Tolkoff-Rubin N, Schifferli JA, et al. Is adsorption an important characteristic of dialysis membranes? Kidney Int 1996; 49: 309-13.
31. Chen ZH, Liu ZH, Yu C, et al. Endothelial dysfunction in patients with severe acute pancreatitis: improved by continuous blood puriication therapy. Int J Artif Organs 2007; 30: 393-400. (Pubitemid 47072695)